The study will measure the impact of Cognixion's novel combination of BCI, AI and AR technology on the ability of amyotrophic lateral sclerosis (ALS) patients, who have lost natural speech, to ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that affects muscle control, and most patients reach a point at which either the disease itself or a necessary ...

A non-invasive and artificial intelligence (AI) powered brain-computer interface (BCI) device developed by US-based startup Cognixion has now entered a crucial patient trial. Ten patients with ...

Alex Knapp is a Forbes senior editor covering healthcare and science.

Cognixion's personalized generative AI communication software in the Axon-R BCI platform will restore the ability to communicate for individuals who have lost the capability to do so through ...

About Cognixion Cognixion is a leader in brain-computer, augmented reality, artificial intelligence and natural user interface technology.